Tvardi Therapeutics TVRD
NASDAQ TVRD
$1.25 -0.03 (-2.34%)
At close: Sep 30, 2026 · 4:00 PM EDT

Tvardi Therapeutics (TVRD) Operating Margin (2013 - 2025)

Updated

Tvardi Therapeutics' Operating Margin came in at -169.48% for Q1 2025, up 1220.03 percentage points from -1389.51% a year earlier and up 572.92 percentage points from the prior quarter.

Analysis

Tvardi Therapeutics (TVRD) Operating Margin (2013 - 2025) Analysis & Trends

Over the trailing twelve months to Mar 31, 2025, Tvardi Therapeutics reported Operating Margin of -370.00%, up 359.19 percentage points year-over-year; for FY2024, it came in at -393.82%, up 185.61 percentage points from FY2023.

  • Operating Margin carries a five-year change of +167.78 percentage points (FY2019 to FY2024).
  • Going back by year, Operating Margin was -579.43% in FY2023 (-370.35 pp), -209.08% in FY2022 (+177.77 pp), -386.85% in FY2021 (-390.83 pp) and 3.99% in FY2020 (+565.58 pp).
  • The Q1 2025 figure represents the highest quarterly Operating Margin since Q2 2022.
  • Year-over-year, Operating Margin has increased for three consecutive quarters, with an average year-over-year change of -26.26 percentage points over the last eight quarters.
  • The fastest year-over-year change in Operating Margin over five years came in Q4 2022 (a gain of 3123.03 percentage points), and the weakest in Q4 2021 (a drop of 4152.92 percentage points).
  • Business Quant data shows TVRD's Operating Margin at -742.41% (Q4 2024), -222.07% (Q3 2024) and -724.62% (Q2 2024) in the three quarters before Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 28.21%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 37.86%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -3.52%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 32.97%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 20.57%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 34.95%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -133.21%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 37.40%
10 Tvardi Therapeutics 11.73 Mn 11.73 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -169.48%
Dec 31, 2024 -742.41%
Sep 30, 2024 -222.07%
Jun 30, 2024 -724.62%
Mar 31, 2024 -1,389.51%
Dec 31, 2023 -1,085.45%
Sep 30, 2023 -593.88%
Jun 30, 2023 -466.46%
Mar 31, 2023 -448.50%
Dec 31, 2022 -960.04%
Sep 30, 2022 -220.52%
Jun 30, 2022 -19.44%
Mar 31, 2022 -582.69%
Dec 31, 2021 -4,083.07%
Sep 30, 2021 -5.54%
Mar 31, 2021 -1,217.62%
Dec 31, 2020 69.85%
Sep 30, 2020 -183.68%
Jun 30, 2020 -459.42%
Mar 31, 2020 -370.70%
API Access

Tvardi Therapeutics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=TVRD&period=max&api_key=YOUR_API_KEY